https://www.ajmc.com/view/dr-jay-edelberg-mavacamten-is-producing-exciting-long-term-results-in-hcm
Patients with hypertrophic cardiomyopathy (HCM) had symptomatic, functional, and structural biomarker changes over the course of a little more than 6 months,...
dr jaylong termedelbergmavacamtenproducing
https://www.fiercebiotech.com/biotech/esc-myokardia-delivers-positive-phase-3-mavacamten-data-showing-effects-thickening-heart
Earlier this year, MyoKardia presented preliminary data showing its long-awaited targeted heart therapy mavacamten could move the needle on certain card
in phaseescmavacamtenboostsheart